Next-Generation Precision Oncology Market Growth Fueled by Liquid Biopsy and AI-Driven Diagnostics
Market Overview The global Precision Oncology Therapies Market is witnessing substantial growth due to increasing advancements in personalized medicine, genomic research, biomarker-based diagnostics, and targeted cancer therapies. Precision oncology focuses on customizing cancer treatment based on an individual patient’s genetic profile, tumor characteristics, and molecular biomarkers, enabling more effective and personalized therapeutic outcomes. According to industry analysis, the market is expected to experience strong expansion during the forecast period as healthcare providers increasingly adopt precision medicine approaches to improve cancer treatment efficacy and reduce adverse side effects. The rising prevalence of cancer worldwide, combined with rapid developments in next-generation sequencing (NGS), companion diagnostics, immunotherapy, and AI-driven drug discovery, is accelerating market growth significantly. The integration of genomic data analytics, artificial...